chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I haven't received the 3rd dose of the vaccine because of respiratory conditions.; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of RESPIRATORY DISORDER (I haven't received the 3rd dose of the vaccine because of respiratory conditions.) and COVID-19 (COVID-19) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RESPIRATORY DISORDER (I haven't received the 3rd dose of the vaccine because of respiratory conditions.) and COVID-19 (COVID-19). At the time of the report, RESPIRATORY DISORDER (I haven't received the 3rd dose of the vaccine because of respiratory conditions.) and COVID-19 (COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications information was not reported. No treatment medications were provided.  Patient had not received the 3rd dose of the vaccine because of respiratory conditions.  Company comment: This is a spontaneous case concerning a patient of unknown age and gender with no medical history reported, who experienced non serious, unexpected events of COVID-19 (AESI) and respiratory disorder. Vaccination date and start date of the events were not provided. Clinical course and treatment details were not disclosed. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a patient of unknown age and gender with no medical history reported, who experienced non serious, unexpected events of COVID-19 (AESI) and respiratory disorder. Vaccination date and start date of the events were not provided. Clinical course and treatment details were not disclosed. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On or about 17-DEC-2008, the patient was inoculated with ZOSTAVAX at a physician's office, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of shingles. On or about 21-MAY-2014, she was treated by a dermatologist for the onset of blistery rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles on her forehead and face. The patient was prescribed valacyclovir (VALTREX) and fluocinide 0.5% ointment for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Persistent pain and limited mobility each day for over a month after the injection. The physician said I had inflammation around the site of injection that manifested as a "lump you have is located on the origin or first part of the triceps tendon and muscle."
Sick; Has cirrhosis of the liver; This is a spontaneous report from a Pfizer-sponsored program Pfizer RXPathways. A contactable consumer (Patient's mother) reported that a 52-year-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient was sick and was in the hospital, and had cirrhosis of the liver and it was getting ready to go on disability. The outcome of events was unknown.  Information on the batch number has been requested.
Sore arm after the 1st shot; This is a spontaneous report from a  sponsored program. A contactable consumer (patient) reported that an 83-year-old female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Lot number and expiration date was not reported), via an unspecified route of administration on 29Jan2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient had her Pfizer Covid-19 vaccine last 29Jan2021 with her 2 friends. patient wants to know if the vaccine is fresh? Patient worried about the clinic as they only have a refrigerator. It took her 20 hrs to get an appointment and patient 2nd shot scheduled on the 19Feb2021. patient had a sore arm after the 1st shot on an unspecified date in 2021. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Patient fainted twice shortly after the vaccination was administered. No signs of anaphylaxis or other allergic reaction. 911 was called by responders determined the patient was fine and able to leave on her own. Patient was not transported to the ER.
Red painful lump on arm by injection site continues to grow over the past 48 hours including pain in my armpit. I've also had extreme flu like symptoms with whole body hurting (skin, muscles and inside my abdomen and chest). Haven't seen a Dr yet because I don't know how abnormal it is.
Area of administration was red, painful, warm and swollen, lasted about 2-3 days before improving. Unable to tell if it was from pneumonia or influenza vaccine.
started getting a strange throbbing head pain under my right eye. then a few days later excruciating pain in my lower tooth radiating throughout my entire mouth and jaw. on the right side. it was the worst pain in my life. unrelenting, throbbing, radiating pain. I almost went to the emergency room since the pain continued for 48 hours without relief. I googled symptoms and found trigeminal neuralgia but ended up at a dental office and required an emergency tooth extraction in tooth #30. I had a root canal there prior so at first I didn't connect the two but the pathology found that I had periapical granuloma, which is inflammation. I do not know if the vaccine caused the inflammation but I believe the vaccine hastened inflammation rapidly in that area. the dental surgeon nor dentist believe there is a connection, but interestingly my mom had a similar experience right after her vaccine. I noticed there is a study testing on "Oral side effects of COVID-19 vaccine" https://pubmed.ncbi.nlm.nih.gov/33483637/
ADVERSE EVENT NOS; This spontaneous report received from a consumer concerned a 9 decade old male of unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: immune issues, and other pre-existing medical conditions included: The patient had not gotten covid. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total administered on APR-2021 for covid-19 prophylaxis.  It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total administered on NOV-2021 for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient just got put into a nursing home (adverse event nos) (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of adverse event nos was not reported. This report was non-serious.
During the course on the vaccines, patient has developed debilitating abdominal pain.  4/15/09 MR received 5/5/08 to 4/13/09. 15 yr WCC 6/13/08 with normal exam.  Recent US (+) for splenomegaly. HPV#1 given. HPV and MCV4 given 8/18/08. Retuned 9/2/08 with c/o ST, chest congestion. DX: LOM, pharyngitis, pneumonia. Returned 9/8/08 with fatigue, nausea and dry heaves. Wheezing on PE. DX:  wheezing.  improved with nebs.  Returned 9/11/08 with stomach and back pain near rib cage. ? gas/constipation.  Returned 10/7/08 with cold sx, chest pain/heaviness and hard to breath.  DX:  URI. Returned 11/19/08 with ST, neck swelling and fatigue. DX:  Pharyngitis/Fatigue. ? Reactivated Mono. 11/21/08 LOM, Pharyngitis. Returned 12/10/08 with c/o stomach and back pain x 1 month.  sharp pains near kidneys. PE (+) for abd tenderness. DX:  Abd pain.  Referred to GI.  Seen 12/24/08. PE WNL.  Impression: Chronic Abd Pain.  Sent for tests. Back to PCP 1/29/09 with UTI. Returned 2/23/09 with c/o lower abd pain, severe x 4 days.  Low grade temp. Pt reports missing a lot of school.  Some constipation. Return to GI 2/25/09. PE (+) for tenderness to palpation of RLQ. DX: Recurrent abd pain. By 4/4/09 pt homebound.  Continued sx.
experienced headache; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration on 01Mar2021, as unknown, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced headache on an unspecified date in Mar2021. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient complained right arm was swelling and redness from elbow down to wrist. Swelling, redness and mild discomfort noted. No complaints with shortness of breath or with breathing. No redness or swelling noted to any other part of the body.  Symptoms started fifteen minutes after vaccine. Monitored patient for additional thirty minute increase. Patient continues to feel well upon leaving facility. No increase in redness, swelling or pain noted. Instructed patient to reach out to physician or call 911 with further concerns. Patient accompanied by daughter. Daughter voices concerns and verbalized understanding of care with leaving facility.
Given vaccines. Told to sit for several minutes. Maybe 5 minutes later the mother and patient came to front desk to schedule next HPV appt. Pt then said she thought she was going to faint and went to the floor, bumping her head slightly against the wall of the appt desk. Was able to answer questions immediately. Pt was placed in shock position, ice pack to base of skull. Dr at pt side. Kept in shock position for several minutes then to seated position for another 5 minutes then released home in care of mother.
Patient experienced a pinch and tight muscle in upper left arm since the vaccine injection. The tightness did not go away for a month.
A non-serious report of Henoch Schonlein Purpura, abdominal pain, joint pain, and rash below the waist line has been received from a nurse concerning a five year-old male. No medical history nor concomitant medications were provided. On 27-Sep-2008, the patient received a dose of FLUMIST. Within hours after receiving FLUMIST on the same day, on 27-Sep-2008, the patient experienced rash below the waist line, abdominal pain and joint pain. The patient was brought to the emergency room by his mother. In the ER, unspecified tests were performed and treatments were administered. The patient was diagnosed with Henoch Schonlein Purpura. The patient was released from the ER and instructed to follow-up with the primary pediatrician. Outcome for the events was considered resolving. The responsible physician assessed the events as not related to FLUMIST.
No additional AE reported; Temperature excursion of 47.9°F for 47 min; This spontaneous report was received from a health care professional and refers to a 14-month-old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 20-DEC-2022, the patient was vaccinated with the first dose of hepatitis A vaccine, inactivated (VAQTA) intramuscular injection, lot number W017343 with expiration date: 13-DEC-2023, administered intramuscularly in right thigh for prophylaxis (strength was not provided). The administered dose of the vaccine experienced a temperature excursion of 47.9 degrees fahrenheit (F) (storage in clinical practice) for 47 min on 01-DEC-2022. (product storage error). Data logger was involved. No information provided regarding a previous temperature excursion. No adverse event was reported.  This is one of several reports received from the same reporter.
Body aches, headache, and nausea that lasted two full days.  Unable to work and Tylenol, Ibuprofen did not lessen the symptoms.  Almost two weeks later I am still having body aches, some nausea and an occasional headache off and on during the day.  I can work but any exercise beyond  normal daily activities causes these symptoms to come up by the end of the day.  I've talked to the pharmacist where I received my vaccination and she had no idea why this was hanging on so long.  I only had a sore arm with the first shot which I had the first of May, 2019.  I will be contacting my physician today to see if I need to see him.  I've never had a fraction to any immunization like this.
Tested positive for Covid-19 on 5/26/2022. Originally experience symptoms in 5/24/2022 (fever, chills, cough, runny nose, mental fog). Symptoms lasted a few days, tapering each day. As of 5/31/2022 still testing positive with antigen test but only slightly sore throat and tired lungs when exercising.   Started molnupira 5/27/2022.
paleness, weakness, fainted collapsed in the parking lot my daughter ran for help, nurse and security came and help me get him up it lasted from 4 to 5min
Came to the emergency room with shortness of breath. and was diagnosed with COVID-19 pneumonia.  Then patient was started on remdesivir and steroids.  Patient started feeling better and patient started breathing on room air.  Patient also had acute kidney injury that was also resolved.  Since patient was stable enough, patient was discharged home on dexamethasone.
Lack of energy; Dehydrate; Fever; Body ache; Headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Lack of energy), DEHYDRATION (Dehydrate), PYREXIA (Fever), ARTHRALGIA (Body ache) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Lack of energy), DEHYDRATION (Dehydrate), PYREXIA (Fever), ARTHRALGIA (Body ache) and HEADACHE (Headache). At the time of the report, ASTHENIA (Lack of energy), DEHYDRATION (Dehydrate), PYREXIA (Fever), ARTHRALGIA (Body ache) and HEADACHE (Headache) outcome was unknown.            No concomitant medications were reported No treatment information was provided
Case was fully vaccinated 02/09/2021. Symptoms began 03/14/2021 . Minor COVID-symptoms (headache, runny nose, sore throat).  Husband is also positive.
aches; Chills; Fever; This is a spontaneous report from a contactable consumer. A 77-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Right on 10Feb2021 (Batch/Lot Number: EL9266) as SINGLE DOSE for covid-19 immunisation. Medical history included from an unknown date and unknown if ongoing Patient History: No. There were no concomitant medications. The patient experienced aches (pain) (non-serious) on 10Feb2021, chills (chills) (non-serious) on 10Feb2021, fever (pyrexia) (non-serious) on 10Feb2021. The outcome of the events aches and chills were reported as recovering. The outcome of the event fever was reported as not recovered.
Chest and back pains initially which subsided within 1/2 hour.  Then my skin felt sensitive all over like I was getting the flu.  Also felt chills as I was going to bed.  Felt better in the morning; although skin still somewhat sensitive.
pt recv vax 4DEC98 & devel profuse watery diarrhea x 5 days then 2 days later had swelling of feet & purpuric rash of lower extremities x48hr;rash completely consistent w/henoch schonlein purpura;
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable consumer.  A 60-year-old adult male patient received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL9266), dose 2 via an unspecified route of administration, on 19Feb2021 (age at vaccination: 59 years), as DOSE 2, SINGLE and dose 1 via an unspecified route of administration, on 29Jan2021 (Lot number: EN5318) (age at vaccination: 59 years), as a DOSE 1, SINGLE both for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient did not had other vaccine in four weeks. The patient did not have Covid prior to the vaccination and tested for the COVID post vaccination. On 19Oct2021, the patient experienced COVID-19 confirmed by positive COVID-19 test (vaccination failure). On 18Oct2021 the patient underwent lab test procedure which includes Nasal swab test resulted positive on 19Oct2021. Outcome of the event COVID-19 was unknown.  No follow-up attempts are possible. No further information is expected.
no adverse effect; multiple patients were vaccinated with improperly stored VAQTA on multiple dates; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 27-DEC-2018, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated(VAQTA) lot # R013858, expiry date 12-JUN-2019 for prophylaxis.  No adverse event was reported. Previous temperature excursion was reported. Data logger was involved.
Patient reports anxiety. increased heart rate. vitals obtained. heart rate 75 oxygen level 97%. patient asked to lay down. water offered monitored for 15 to 20 minutes. Patient became fine and drove down.
tested positive for COVID virus; tested positive for COVID virus; This is a spontaneous report from a Pfizer-sponsored program. A contactable other HCP (health care worker, patient) reported that a 31-year-old female patient received 1st dose of BNT162B2 (COVID 19 Vaccine, Batch/lot number: EL0140) on 23Dec2020 at single dose for covid-19 immunization. Medical history and concomitant drug were not reported. She received the first dose of the vaccine 23Dec2020. Then, on 05Jan2021, she tested positive for the COVID virus. She was supposed to get the second dose of the Vaccine on 13Jan2021. She was put on quarantine. She is wondering if she can she still get the vaccine or does she need to wait. Outcome of the event was unknown.  No further information is expected. Information about lot/batch number has been obtained.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.
it was rpt pt was expecting period 6sept. on 9sept & on 21sept pregnancy tests performed & pt believes it may have affected her norm cycle pt also exp hot flashes.
Low-grade fever: 99.9. Substantial swelling of thigh on left leg, larger than the vaccine admin site. HIVES at vaccine admin site, hives spread over next few days, call doctor on Saturday to ask if can give Benadryl. Hives last a total of 6 days, they respond to the Benadryl, first by just reducing back to only covering the area at the vaccine sites on the thighs, then becoming smaller, then just disappearing. Hoarsness of voice begins at same time, Hoarseness lasts 2 weeks post vaccine admin. Please note: As same vaccines are usually administered at 4 month visit per recommended vaccine administration schedule, spoke with pediatrician about spacing out recommended vaccines e.g. instead of having all 8 vaccines administered at once again... doing one vaccine (or combo vaccine) a week in an attempt to a. identify the one that caused the allergy and/or b. reduce the chance of a repeated allergy by introducing less vaccines at once. Fingers crossed this works to address the problem and we see no further reactions/illness.
Soon after injection patient experienced a syncope event. Patient fell forward and hit head. EMS was called and took the patient to the hospital. Vital signs remained strong. No swelling or trouble breathing occurred.
had issues with weakness, cheastpains, fatigue  28th went to a Gi for a auto immune issue lab showed autoimmune vasculitis
11/24 c/o weakness, muscle fatigue, the muscles in her thighs and above her elbows especially. When she exerts her muscles she feels stronger than when she is relaxed. She feels like her muscles are "going to sleep". Went to the ER 11/25/04. EKG and blood tests were OK. A chest x-ray revealed a patch that could be pnuemonia. She has had a cold and has had a little cough since September. They Rxed a Z-pack. She saw her Dr. 11/30 because of the continued muscle weakness. A CAT scan of her chest and blood work were normal. She is scheduled for pulmonary tests and a stress test on 12/13/04.
I feel out of it since I got the vaccine, like I am in a fog, my reactions seem slower than usual. Not myself a week and a day later,
Chills (shivering jaw), shaking, aches, fatigue, arm pain at injection site (inability to lift arm without pain), general unwell feeling beginning the evening following the first dose of the COVID vaccine
Within 30 minutes of FLUMIST administration developed headache, dizziness, excessive blinking, slight nausea, no fever, no vomiting, slight photophobia, no blurry vision.
7 days post injection, lump on left arm pit formed. Tender to the touch. Grew the next day, then started to decrease in size and tenderness.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose: 01/06/21, Pfizer Lot#EL3248 2nd dose: 01/27/21,Pfizer Lot# EL9262 Diagnosed covid positive:04/03/21 Exposure:Home Symptoms:Fatigue,muscle aches,sinus congestion
Had an intense no treatable headache for over 8 months. The headache developed 2 weeks after the second shot. Was unable to work for about a month because the headache was so bad. Ended up being admitted to the hospital for 6 days giving me strong narcotics and DHE and steroids every day nothing seemed to help the pain. While in the hospital they put me on a 5 lead heart monitor and noticed my heart would be dangerously low at about 30 then spike to 150 BPM in about 12 second. Sent me home on a 30 day heart monitor. Results were normal but my heart beat still is jumping around like that now even 8 months later
Left leg bruised, swollen and hot to touch at bottom immunization site. Contacting doctors office did not clarify which immunization caused reaction. Was informed that it probably was IPV.
Cellulitis, antibiotics given Redness, itching, hot to touch, hard  Symptoms began 2 days after vaccine was administered
Patient received 1st dose of Moderna at the Health Department even though patient was under 18 years of age. Patient care services coordinator advised to give the patient 2nd dose to complete the series based on clinical guidance. Patient's parent was aware vaccine not indicated for under 18 years of age. NO adverse reaction @ time of vaccination.